Newsroom
Home > Newsroom
340B In The News
February 14, 2019
Axios: Consolidation doesn’t improve care
Between the lines: Politically, an age-restricted Medicare buy-in is about as moderate as it gets for Democrats in the age of "Medicare for All."
340B In The News
January 4, 2019
Becker’s: 340B hospitals saw greater per-patient drug spend than counterparts, study finds
Hospitals that recently enrolled in the 340B drug pricing program saw greater increases in per-patient drug spend compared to non-340B hospitals, according to a Berkeley Research Group study funded by the Pharmaceutical Research and Manufacturers of America, a drug lobby.
340B In The News
December 28, 2018
Politico Pro: Court blocks Trump cuts to drug discount program
A federal court has blocked the Trump administration’s cuts to a federal drug discount program, ruling that HHS does not have the authority to impose the steep pay reductions.
340B In The News
November 16, 2018
The Evidence Is Clear: Policymakers Must Get 340B Back on Track
Over the past year, there has been a growing body of evidence that the 340B program doesn’t always best serve vulnerable or uninsured patient populations. Evidence has also raised questions about how some hospitals use the 340B program.
340B In The News
November 8, 2018
Daily Caller: Hollow promises on feds’ drug discount program
After mounting evidence from government watchdogs, academics, patient advocates, lawmakers, and concerned citizens that the safety-net 340B drug discount program was enriching hospitals at the expense of the low-income patients it was intended to serve, the American Hospital Association (AHA) finally announced new principles that they claim will ensure “good stewardship” of the program.
340B In The News
October 28, 2018
Washington Examiner: 340B drug program was created to help patients, not boost hospital profits
Enacted more than 25 years ago with bipartisan support, the 340B program was designed to help healthcare safety net providers deliver more affordable outpatient prescription drugs to vulnerable or uninsured patients.
340B In The News
September 24, 2018
GAO Raises Additional Concerns With 340B Contract Pharmacies and Hospitals
The 340B drug discount program — a vital safety-net program created to help millions of vulnerable or uninsured patients receive care — is no longer benefiting many of the patients it was meant to serve. That’s according to mounting findings from congressional investigations, independent economists, and government watchdogs. Two new studies released by the Government Accountability Office (GAO) add to these growing concerns, looking specifically at contract pharmacies and hospitals in the 340B program. GAO’s latest conclusions provide further evidence more must be done to fix the 340B program and bring it back to the original intent of helping patients.
340B In The News
September 18, 2018
AIR340B Encouraged by 340B Principles Announced by AHA, Looks to Regulatory and Congressional Action to Keep Momentum Going
The AIR340B Coalition issued the following statement in response to the new principles for good stewardship of the 340B program announced by the American Hospital Association (AHA) today.